StockDuty ← Dashboard Aug 11, 2026 05:44 PM ET
SignalCorporate

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

What changed
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus
Why it matters
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →